Medtronic Neuromodulation - Activa Dystonia Therapy Kit - Class 1 Recall
Medtronic DBS Therapy for Dystonia Kit, models 3317, 3319, 3337 and 3339. Sterile and Non-Pyrogenic. Product Usage: Dystonia Therapy Kit is indicated for unilateral or bilateral stimulation of the internal globus pallidus (GPi) or the subthalamic nucleus (STN) to aid in the management of chronic, intractable (drug refractory) primary dystonia, including generalized and/or segmental dystonia, hemidystonia, and cervical dystonia (torticollis).
We present anesthetic nuances to be considered in the management of a patient with Segawa's disease along with a pertinent review of the literature.
Condition: Dystonia, Focal Intervention: Drug: botulinum toxin A Sponsors: University of Roma La Sapienza; Ipsen Recruiting
In recent years, cerebellar abnormalities have gained increasing attention as possible physiopathological substratum of idiopathic cervical dystonia (ICD), but a consistent pattern of cerebellar structural modifications has not yet been established. We systematically investigated the presence of volumetric alterations of cerebellar gray (GM) and white matter (WM) in ICD patients, as well as their clinical relevance.
This study attempts to explore possible causes of SID.Materials and MethodsRetrospectively collected clinical data on 32 patients who underwent STN ‐DBS between October 2016 and April 2019 were analyzed. Clinical outcomes were assessed pre‐ and post‐surgery, using the Burke–Fahn–Marsden dystonia rating scale (BFMDRS). Patients were divided into a dyskinesia group and a non‐dyskinesia group, according to whether or not they experienc ed persistent SID during follow‐up. The coordinates of the active contacts were calculated from post‐operative computerized tomography or magnetic resonance imaging, usi...
PMID: 32959737 [PubMed - as supplied by publisher]
Conclusion: GA was associated with better MRI sequences than intravenous sedation or no anesthesia.Stereotact Funct Neurosurg
To perform phenotype and genotype characterization in myoclonus-dystonia patients and to validate clinical rating tools.
Abstract BACKGROUND AND RATIONALE: Hyperkinetic movement disorders represent a heterogeneous group of diseases, different from a genetic and clinical perspective. In the past, neurophysiological approaches provided different, sometimes contradictory findings, pointing to an impaired cortical inhibition as a common electrophysiological marker. Our aim was to evaluate changes in interhemispheric communication in patients with idiopathic cervical dystonia (ICD) and spinocerebellar ataxias (SCAs). MATERIALS AND METHODS: Eleven patients with ICD, 7 with genetically confirmed SCA2 or SCA3, and 10 healthy volunteers...